Latest Period
Q2 2026
Security Snapshot
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) Institutional Ownership
CUSIP: 50127T109
13F Institutional Holders and Ownership History from Q4 2015 to Q2 2026
Institutions Reporting
218
Shares (Excl. Options)
86,946,762
Price
$10.97
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- KURA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 86,946,762
- Total 13F value
- $953,113,854
- Portfolio coverage rank
- 0%
- Share change
- +2,587,676
- Value change
- +$31,231,637
- Number of holders
- 218
- Shares outstanding
- 88,406,412
- SEC-reported price per share
- $10.89
- Insider filing price
- $10.89
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 50127T109.
- 218 institutions reported positions in Q2 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 220 to 218 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $686,455,640 to $953,113,854.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 218 institutions filings for Q2 2026.
Security key
50127T109
Latest holder period
Q2 2026
13F holders
218
13D/G owners
8
CIK / CUSIP context first
Open Q2 2026 holders
KURA full holder history
Kura Oncology, Inc. SEC filings
Kura Oncology, Inc. company facts
Kura Oncology, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 50127T109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
KURA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 10% | +31% | $76,791,609 | +$24,465,506 | 8,677,018 | +47% | BVF PARTNERS L P/IL | 30 Sep 2025 |
| MONTANOVA CAPITAL, LLC | 9.7% | +3.3% | $103,591,098 | +$12,254,218 | 8,575,422 | +13% | Montanova Capital, LLC | 30 Jun 2026 |
| BlackRock, Inc. | 7.8% | -24% | $41,202,116 | -$10,448,902 | 6,329,050 | -20% | BlackRock, Inc. | 31 Mar 2025 |
| STATE STREET CORP | 5.7% | $45,218,095 | 4,931,090 | STATE STREET CORPORATION | 31 Dec 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $36,006,242 | 4,428,812 | Vanguard Capital Management | 31 Mar 2026 | |||
| EcoR1 Capital, LLC | 4.8% | $23,520,000 | 4,200,000 | EcoR1 Capital, LLC | 30 Jun 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 4.9% | $26,070,011 | 4,004,610 | RA Capital Management, L.P. | 31 Mar 2025 | |||
| ARMISTICE CAPITAL, LLC | 4.2% | -24% | $32,839,440 | -$10,548,000 | 3,736,000 | -24% | Armistice Capital, LLC | 31 Mar 2026 |
As of 30 Jun 2026, 218 institutional investors reported holding 86,946,762 shares of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA). This represents 98% of the company’s total 88,406,412 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
78%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 10,509,233 | +9% | 0% | $115,286,283 |
| MONTANOVA CAPITAL, LLC | 9.7% | 8,575,422 | 0% | 2% | $94,072,379 |
| BVF INC/IL | 9.6% | 8,445,769 | 0% | 2.4% | $92,650,086 |
| STATE STREET CORP | 6% | 5,329,208 | +18% | 0% | $58,461,412 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 3,916,164 | +3.4% | 0% | $42,960,319 |
| ARMISTICE CAPITAL, LLC | 4.2% | 3,678,000 | -1.6% | 1.1% | $40,347,660 |
| AQR CAPITAL MANAGEMENT LLC | 3.5% | 3,126,727 | +47% | 0.01% | $34,300,201 |
| GOLDMAN SACHS GROUP INC | 2.6% | 2,265,171 | +58% | 0% | $24,848,925 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 2,229,958 | +9.6% | 0% | $24,468,022 |
| ALETHEA CAPITAL MANAGEMENT, LLC | 2.5% | 2,167,938 | +42% | 9.9% | $23,782,280 |
| Prosight Management, LP | 2.3% | 2,021,964 | -40% | 3.8% | $22,180,945 |
| Deep Track Capital, LP | 2.2% | 1,978,565 | -25% | 0.32% | $21,704,858 |
| RENAISSANCE TECHNOLOGIES LLC | 1.9% | 1,663,765 | +5.1% | 0.03% | $18,251,502 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.6% | 1,410,275 | 0.01% | $15,470,717 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5% | 1,329,941 | +8.1% | 0% | $14,589,453 |
| NAN FUNG TRINITY (HK) LTD | 1.3% | 1,174,880 | +10% | 1.3% | $12,888,434 |
| Qube Research & Technologies Ltd | 1.3% | 1,169,884 | -29% | 0.01% | $12,833,627 |
| DIMENSIONAL FUND ADVISORS LP | 1.3% | 1,169,189 | -18% | 0% | $12,826,227 |
| BANK OF AMERICA CORP /DE/ | 1.3% | 1,160,921 | -5.6% | 0% | $12,735,304 |
| MORGAN STANLEY | 1.3% | 1,160,310 | -0.32% | 0% | $12,728,606 |
| Connor, Clark & Lunn Investment Management Ltd. | 1.1% | 996,114 | +24% | 0.02% | $10,927,371 |
| UBS Group AG | 1.1% | 964,636 | -7.3% | 0% | $10,582,057 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.1% | 948,974 | +58% | 0.04% | $10,410,245 |
| NORTHERN TRUST CORP | 0.94% | 831,160 | +9.9% | 0% | $9,117,826 |
| MILLENNIUM MANAGEMENT LLC | 0.8% | 711,332 | -55% | 0.01% | $7,803,312 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
43
Latest
Q2 2026
Rows shown
1-25 of 43
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 86,946,762 | $953,113,854 | +$31,231,637 | $10.97 | 218 |
| 2026 Q1 | 84,423,850 | $686,455,640 | -$12,595,125 | $8.13 | 220 |
| 2025 Q4 | 85,261,971 | $885,726,020 | +$20,154,669 | $10.39 | 212 |
| 2025 Q3 | 83,884,309 | $742,481,432 | +$26,729,034 | $8.85 | 197 |
| 2025 Q2 | 82,161,271 | $474,076,451 | +$3,886,077 | $5.77 | 180 |
| 2025 Q1 | 80,481,583 | $531,240,145 | -$1,742,391 | $6.60 | 183 |
| 2024 Q4 | 78,800,102 | $686,302,860 | -$217,671,932 | $8.71 | 184 |
| 2024 Q3 | 82,360,607 | $1,606,956,703 | +$4,044,498 | $19.54 | 178 |
| 2024 Q2 | 80,489,635 | $1,657,260,003 | -$4,649,743 | $20.59 | 173 |
| 2024 Q1 | 80,704,151 | $1,721,386,349 | +$47,334,824 | $21.33 | 162 |
| 2023 Q4 | 78,750,714 | $1,132,429,796 | +$48,405,539 | $14.38 | 138 |
| 2023 Q3 | 75,320,060 | $686,894,075 | -$2,210,555 | $9.12 | 131 |
| 2023 Q2 | 75,143,461 | $795,074,726 | +$20,118,060 | $10.58 | 147 |
| 2023 Q1 | 72,452,228 | $885,285,317 | +$27,367,401 | $12.23 | 140 |
| 2022 Q4 | 70,164,281 | $870,596,716 | -$25,367,145 | $12.41 | 139 |
| 2022 Q3 | 71,584,721 | $977,803,865 | -$10,119,008 | $13.66 | 144 |
| 2022 Q2 | 68,658,415 | $1,258,498,156 | +$54,233,601 | $18.33 | 142 |
| 2022 Q1 | 65,777,551 | $1,057,605,942 | +$39,092,796 | $16.08 | 142 |
| 2021 Q4 | 64,108,565 | $897,784,334 | -$107,625,141 | $14.00 | 143 |
| 2021 Q3 | 66,738,474 | $1,250,027,023 | -$22,664,956 | $18.73 | 149 |
| 2021 Q2 | 67,619,494 | $1,409,907,095 | -$33,759,405 | $20.85 | 163 |
| 2021 Q1 | 68,584,982 | $1,942,401,972 | +$106,818,236 | $28.27 | 162 |
| 2020 Q4 | 65,052,975 | $2,124,984,562 | +$353,968,960 | $32.66 | 192 |
| 2020 Q3 | 53,818,393 | $1,648,931,451 | +$50,643,099 | $30.64 | 160 |
| 2020 Q2 | 52,442,231 | $855,540,393 | +$213,208,168 | $16.30 | 129 |